HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Use of Plaferon LB for cardiac preconditioning during experimental ischemia/reperfusion injury in rabbits].

Abstract
The main goal of research was to study potential of Plaferon LB for cardiac preconditioning during experimental ischemia/reperfusion injury in rabbits. 30 rabbits (2.5-3.0 kg) were used in experiment. They were divided in 3 groups and 6 subgroups (n=5). In I group experimental design of m/i was performed by proximal ligation of left coronary artery (LCA) (2-6 hours). In II group on the 2 and 6 hour ligature was removed - reperfusion during 1 hour. In III group before ligation of LCA animals was administered Plaferon LB (0.2 mg/kg). The animals were under electrocardiographic monitoring. Troponin I was measured in blood. In II group after 1 hour of reperfusion Troponin I concentration was higher than in I group after 2 and 6 hours. In II group electrocardiographic data was worsened (rhythm and heart rate). In III group these changes were less marked. Obtained data confirm enhancement of myocardial injury during the reperfusion. Cardiac preconditioning by Plaferon LB significantly decreased pathologic indices.
AuthorsT O Ubilava, I I Megreladze, M B Dzhangavadze, N G Khodeli, Z A Chkhaidze
JournalGeorgian medical news (Georgian Med News) 2007 Jul-Aug Issue 148-149 Pg. 73-9 ISSN: 1512-0112 [Print] Georgia (Republic)
PMID17921551 (Publication Type: English Abstract, Journal Article)
Chemical References
  • Neuropeptides
  • plaferon
Topics
  • Animals
  • Disease Models, Animal
  • Electrocardiography
  • Ischemic Preconditioning, Myocardial (methods)
  • Myocardial Reperfusion Injury (diagnosis, drug therapy, therapy)
  • Neuropeptides (therapeutic use)
  • Rabbits
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: